New Treatments
Transforming TB Treatment
TB Alliance is leading the global effort to develop faster, simpler, and more effective cures for all forms of TB.
Learn More:
![Transforming_01_NOBG](https://www.tballiance.org/wp-content/uploads/2025/01/Transforming_01_NOBG-1024x683.png)
![100K-85_graphic-01](https://www.tballiance.org/wp-content/uploads/2025/01/100K-85_graphic-01-1024x576.png)
The Latest from TB Alliance
We cannot afford to stop until our treatments are available to everyone who needs them.
Access to the latest treatment innovations is a human right. Read more about how we’re working to end this age-old disease.
TB By The Numbers
Million
Tuberculosis (TB) is a global pandemic, killing someone approximately every 24 seconds — about 1.3 million people every year.
6-Months
Too many people with TB are still given older regimens that too too long to cure, are too complicated to administer, and can be toxic.
+ Projects
Promise in the pipeline means new hope in stopping TB.
![Delivering Treatments_03_NOBG](https://www.tballiance.org/wp-content/uploads/2025/01/Delivering-Treatments_03_NOBG-1024x683.png)
REACHING THOSE IN NEED
Delivering Treatments
TB Alliance’s mission is not complete until new drugs are in the hands of those who need them.
More News:
TRANSFORMING TB TREATMENT
Charting the Course
We’ve all come to know the impact of infectious diseases, but we also know the power of science.
More News:
![Charting the Course_01-NOBG](https://www.tballiance.org/wp-content/uploads/2025/01/Charting-the-Course_01-NOBG-1-1024x844.png)
TB Alliance manages the largest pipeline of new TB drugs in history.
Ariel Pablos-Mendez on the past, present, and future of TB research and the TB Alliance
February 8th marks the 25th anniversary of the signing of the Cape Town Declaration, which…
Funding for TB and Neglected Disease Research Must Increase to Realize Promise of New Technologies
Statement from TB Alliance on release of the G-FINDER 2024 Neglected Disease R&D Report NEW…
Historically Successful Global Access Campaign for Pretomanid and BPaL-based Regimens Continues with Major Milestones in BRICS Countries
Throughout 2024, one of TB Alliance’s foremost priorities has been ensuring that pretomanid and BPaL-based…